Insider · CIK 0001930479

DeSimone Jill

Reports to the SEC for 4 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001930479

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−1,004 sh	$312.83	−$314K	4,957
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−683 sh	$306.77	−$210K	12,804
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−1,240 sh	$308.24	−$382K	11,564
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−999 sh	$309.38	−$309K	10,565
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−1,750 sh	$310.89	−$544K	8,815
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−2,854 sh	$311.91	−$890K	5,961
2026-06-24	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,034 sh	—	—	0
2026-06-24	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,566 sh	—	—	0
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−837 sh	$315.70	−$264K	2,337
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−1,279 sh	$314.90	−$403K	3,174
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−504 sh	$313.66	−$158K	4,453
2026-06-24	PRAXPraxis Precision Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,566 sh	$44.25	+$379K	10,903
2026-06-24	PRAXPraxis Precision Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,034 sh	$147.30	+$447K	13,937
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−10 sh	$301.44	−$3,014.4	13,927
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−120 sh	$303.13	−$36.4K	13,807
2026-06-24	PRAXPraxis Precision Medicines, Inc.S Sale	Director	SSale	−320 sh	$305.31	−$97.7K	13,487
2026-06-10	PRAXPraxis Precision Medicines, Inc.A Award	Director	AAward	+1,371 sh	—	—	2,337
2026-06-10	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+648 sh	—	—	648
2025-06-26	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,520
2024-06-20	Oncternal Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+2,200 sh	—	—	2,200
2024-06-11	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+24.2K sh	—	—	24,200
2024-06-05	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,566 sh	—	—	8,566
2024-04-03	Kinnate Biopharma Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2024-03-07	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+44.8K sh	—	—	44,766
2023-10-05	PRAXPraxis Precision Medicines, Inc.P Purchase	Director	PPurchase	+14.5K sh	$1.75	+$25.4K	14,500
2023-06-28	Oncternal Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+25K sh	—	—	25,000
2023-06-12	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29K sh	—	—	28,981
2023-03-01	Kinnate Biopharma Inc.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2023-01-04	Oncternal Therapeutics, Inc.Stock OptionA Award	Director	AAward	+50K sh	—	—	50,000
2022-05-23	PRAXPraxis Precision Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.5K sh	—	—	45,511

Recent filings

Accepted (ET)
Jun 264
DeSimone Jill0001930479-26-000003
SEC(opens sec.gov)
Jun 124
DeSimone Jill0001689548-26-000061
SEC(opens sec.gov)
Jun 274
DeSimone Jill0001689548-25-000078
SEC(opens sec.gov)
Jun 244
DeSimone Jill0000950170-24-076704
SEC(opens sec.gov)

Companies

Address

C/O PRAXIS PRECISION MEDICINES, INC. 99 HIGH STREET, 30TH FLOOR

BOSTON, MA, 02110